Effect of antifibrotics on short-term outcome after bilateral lung transplantation: a multicentre analysis

Keywords

• Europe
• Female
• Humans
• Indoles/*therapeutic use
• Lung Diseases, Interstitial/*mortality/*therapy
• Lung Transplantation/methods
• Male
• Middle Aged
• Postoperative Care
• Pyridones/*therapeutic use
• Retrospective Studies
• Steroids/*therapeutic use
• Treatment Outcome
• Boehringer Ingelheim and Roche, outside the submitted work. Conflict of interest:
• T. Welte has received grants to his institution from Boehringer and Roche during
• the conduct of the study, lecture and advisory board fees from Boehringer, and
• has participated in an advisory board on anti-infectives for Roche, outside the
• submitted work. Conflict of interest: J. Gottlieb has received fees for board
• membership from Gilead, MSD, Biotest and Therakos, for consultancy from Chiesi,
• IEK Consulting, Gilead and Breath Therapeutics, and for expert testimony from GLG
• Research, Navigant and KeyQuest
• has received grants or has grants pending from
• Alnylam and Gilead
• and has received payment for lectures from Gilead,
• Boehringer, Novartis, Basilea, Berlin Chemie and Astellas, and for travel,
• accommodation or meeting expenses from Biotest.